368 related articles for article (PubMed ID: 23472148)
1. Internalization mechanisms of the epidermal growth factor receptor after activation with different ligands.
Henriksen L; Grandal MV; Knudsen SL; van Deurs B; Grøvdal LM
PLoS One; 2013; 8(3):e58148. PubMed ID: 23472148
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of EGFR ligands on endocytic sorting of the receptor.
Roepstorff K; Grandal MV; Henriksen L; Knudsen SL; Lerdrup M; Grøvdal L; Willumsen BM; van Deurs B
Traffic; 2009 Aug; 10(8):1115-27. PubMed ID: 19531065
[TBL] [Abstract][Full Text] [Related]
3. Anti-EGFR monoclonal antibodies which act as EGF, TGF alpha, HB-EGF and BTC antagonists block the binding of epiregulin to EGFR-expressing tumours.
Modjtahedi H; Komurasaki T; Toyoda H; Dean C
Int J Cancer; 1998 Jan; 75(2):310-6. PubMed ID: 9462724
[TBL] [Abstract][Full Text] [Related]
4. Role of Grb2 in EGF-stimulated EGFR internalization.
Yamazaki T; Zaal K; Hailey D; Presley J; Lippincott-Schwartz J; Samelson LE
J Cell Sci; 2002 May; 115(Pt 9):1791-802. PubMed ID: 11956311
[TBL] [Abstract][Full Text] [Related]
5. The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4.
Riese DJ; Kim ED; Elenius K; Buckley S; Klagsbrun M; Plowman GD; Stern DF
J Biol Chem; 1996 Aug; 271(33):20047-52. PubMed ID: 8702723
[TBL] [Abstract][Full Text] [Related]
6. P130Cas attenuates epidermal growth factor (EGF) receptor internalization by modulating EGF-triggered dynamin phosphorylation.
Kang YS; Kim W; Huh YH; Bae J; Kim JS; Song WK
PLoS One; 2011; 6(5):e20125. PubMed ID: 21625594
[TBL] [Abstract][Full Text] [Related]
7. Differential activation of epidermal growth factor (EGF) receptor downstream signaling pathways by betacellulin and EGF.
Saito T; Okada S; Ohshima K; Yamada E; Sato M; Uehara Y; Shimizu H; Pessin JE; Mori M
Endocrinology; 2004 Sep; 145(9):4232-43. PubMed ID: 15192046
[TBL] [Abstract][Full Text] [Related]
8. EGFR and EGFR ligands in serum in healthy women; reference intervals and age dependency.
Kjær IM; Olsen DA; Alnor A; Brandslund I; Bechmann T; Madsen JS
Clin Chem Lab Med; 2019 Nov; 57(12):1948-1955. PubMed ID: 31323001
[TBL] [Abstract][Full Text] [Related]
9. Suppression of EGFR endocytosis by dynamin depletion reveals that EGFR signaling occurs primarily at the plasma membrane.
Sousa LP; Lax I; Shen H; Ferguson SM; De Camilli P; Schlessinger J
Proc Natl Acad Sci U S A; 2012 Mar; 109(12):4419-24. PubMed ID: 22371560
[TBL] [Abstract][Full Text] [Related]
10. Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx.
Horiuchi K; Le Gall S; Schulte M; Yamaguchi T; Reiss K; Murphy G; Toyama Y; Hartmann D; Saftig P; Blobel CP
Mol Biol Cell; 2007 Jan; 18(1):176-88. PubMed ID: 17079736
[TBL] [Abstract][Full Text] [Related]
11. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands.
Sahin U; Weskamp G; Kelly K; Zhou HM; Higashiyama S; Peschon J; Hartmann D; Saftig P; Blobel CP
J Cell Biol; 2004 Mar; 164(5):769-79. PubMed ID: 14993236
[TBL] [Abstract][Full Text] [Related]
12. Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family.
Barnard JA; Graves-Deal R; Pittelkow MR; DuBois R; Cook P; Ramsey GW; Bishop PR; Damstrup L; Coffey RJ
J Biol Chem; 1994 Sep; 269(36):22817-22. PubMed ID: 8077234
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptors destined for the nucleus are internalized via a clathrin-dependent pathway.
De Angelis Campos AC; Rodrigues MA; de Andrade C; de Goes AM; Nathanson MH; Gomes DA
Biochem Biophys Res Commun; 2011 Aug; 412(2):341-6. PubMed ID: 21821003
[TBL] [Abstract][Full Text] [Related]
14. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency.
Hinkle CL; Sunnarborg SW; Loiselle D; Parker CE; Stevenson M; Russell WE; Lee DC
J Biol Chem; 2004 Jun; 279(23):24179-88. PubMed ID: 15066986
[TBL] [Abstract][Full Text] [Related]
15. Novel mechanism for regulation of epidermal growth factor receptor endocytosis revealed by protein kinase A inhibition.
Salazar G; González A
Mol Biol Cell; 2002 May; 13(5):1677-93. PubMed ID: 12006662
[TBL] [Abstract][Full Text] [Related]
16. Polyubiquitination of the epidermal growth factor receptor occurs at the plasma membrane upon ligand-induced activation.
Stang E; Johannessen LE; Knardal SL; Madshus IH
J Biol Chem; 2000 May; 275(18):13940-7. PubMed ID: 10788520
[TBL] [Abstract][Full Text] [Related]
17. ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis.
Révillion F; Lhotellier V; Hornez L; Bonneterre J; Peyrat JP
Ann Oncol; 2008 Jan; 19(1):73-80. PubMed ID: 17962208
[TBL] [Abstract][Full Text] [Related]
18. Effects of different ligands on epidermal growth factor receptor (EGFR) nuclear translocation.
Faria JAQA; de Andrade C; Goes AM; Rodrigues MA; Gomes DA
Biochem Biophys Res Commun; 2016 Sep; 478(1):39-45. PubMed ID: 27462018
[TBL] [Abstract][Full Text] [Related]
19. Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor.
Reznik TE; Sang Y; Ma Y; Abounader R; Rosen EM; Xia S; Laterra J
Mol Cancer Res; 2008 Jan; 6(1):139-50. PubMed ID: 18234969
[TBL] [Abstract][Full Text] [Related]
20. Heterodimerization of the epidermal-growth-factor (EGF) receptor and ErbB2 and the affinity of EGF binding are regulated by different mechanisms.
Johannessen LE; Haugen KE; østvold AC; Stang E; Madshus IH
Biochem J; 2001 May; 356(Pt 1):87-96. PubMed ID: 11336639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
